SC 13D/A

CATALYST BIOSCIENCES, INC. - AMEND. #4

Company: GYRE THERAPEUTICS, INC.
Filed: February 11, 2016
Accession Number: 0001072613-16-000583

View Document ↗ View on SEC.gov ↗